IHS Chemical Week

Regions :: North America :: U.S.

Akzo Nobel Completes Pharma Division Sale

11:18 AM MST | November 19, 2007 |

Alex Scott

Akzo Nobel said today that it has completed the sale of its pharmaceuticals division Organon Biosciences to Schering-Plough for EU 11 billion ($16.1 billion). Confirmation of the completion of the transaction comes after Schering-Plough received all the necessary approvals, including clearance from the U.S. Federal Trade Commission and the European Commission. The sale paves the way for Akzo’s planned purchase of ICI. “It is with mixed emotions that we say goodbye to these businesses, which have been part of Akzo Nobel for so many years,” says...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa